Allergan successfully completes Kythera acquisition
KYBELLA® first FDA-approved non-surgical injection for submental fullness bolsters Allergan’s world-class facial aesthetics portfolio
Read MoreKYBELLA® first FDA-approved non-surgical injection for submental fullness bolsters Allergan’s world-class facial aesthetics portfolio
Read MoreKYBELLA injection (deoxycholic acid, KYTHERA Biopharmaceutcials), also known as ATX-101, has been FDA approved for contouring moderate to severe convexity or fullness associated with submental fat in adults. KYBELLA is (more…)
Read More